AIDS and HIV Vaccine
Antibody-resistant infection poorly controlled after DNA prime/boost regimens
Published in AIDS Weekly, July 15th, 2002
"In the rhesus macaque model, some protection was afforded by DNA/recombinant viral vector vaccines," according to Helen Horton, Wisconsin Regional Primate Research Center, and a multicenter team in the U.S. and Europe and at PowderJect Vaccines, Inc., in Madison, Wisconsin.
However, many HIV strains may not be as vulnerable as the simian strain used in many primate studies, Horton and coauthors found.
Researchers studying candidate vaccines often...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2002-07-15)
More Articles from AIDS Weekly
- AIDS and HIV Therapy
Unsuccessful antiretroviral therapy can lead to brain damage - AIDS and HIV Tuberculosis
Effects of tuberculosis and HIV-2 coinfection elucidated - AIDS and HIV Cancer
Ritonavir can reduce Kaposi sarcoma risk - AIDS and HIV Therapy
Peroxisome proliferator-activated receptor (gamma) agonists show promise - AIDS Prevention
Large-scale testing of new AIDS vaccine postponed - AIDS Prevention
U.N. report says 'dramatic changes' in sexual behavior needed in many poor countries - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
